About Edgar Jannotta, Jr.
Edgar Jannotta, Jr. is a board observer at Neela Therapeutics.
Form D filings also name Edgar Jannotta, Jr. as a director at Alcyone Therapeutics.
Edgar Jannotta, Jr. first appears on SEC filings in 2013.
Experience
This experience comes from SEC filings. The years are when the filings name Edgar Jannotta, Jr. in the role, so the role may have started earlier or lasted longer.
Neela Therapeutics, Inc.
Board Observer
2025 – 2026 · Lunenburg, MA
Develops precision therapies for children with rare and serious diseases.
Key Colleagues at Startups
The people Edgar Jannotta, Jr. works with at each company, as listed on that company's latest Form D.
Neela Therapeutics, Inc. · Form D/A, May 26, 2026
RU
Richard Upton
Partner, Harbor Light Capital Partners and director
NR
Norbert Riedel
Chairman of the Board
DD
David Donabedian
Founding CEO, Newleos Therapeutics and director
PA
Pj Anand
Founder, President and Chief Executive Officer, director
SO
Stephen Oesterle
Director
Alcyone Therapeutics, Inc. · Form D/A, Jan 8, 2025
DD
David Donabedian
Director
NR
Norbert Riedel
Director
SO
Stephen Oesterle
Director
PA
Pj Anand
Chief Executive Officer and director
RU
Richard Upton
Director
CD
Cameron Durrant
Director